Long-term complications, extraintestinal manifestations, and mortality in adult Crohn's disease in population-based cohorts.
about
Onset of psoriasis in patients with inflammatory bowel disease treated with anti-TNF agentsNod-like receptor pyrin domain-containing protein 6 (NLRP6) controls epithelial self-renewal and colorectal carcinogenesis upon injuryDisability due to Inflammatory Bowel Disease Is Correlated with Drug Compliance, Disease Activity, and Quality of LifeA nationwide population-based study of the inflammatory bowel diseases between 1998 and 2008 in TaiwanGlutamine supplementation attenuates expressions of adhesion molecules and chemokine receptors on T cells in a murine model of acute colitis.Clinical epidemiology and phenotypic characteristics of Crohn's disease in the central region of Saudi Arabia.Frequency, phenotype, outcome, and therapeutic impact of skin reactions following initiation of adalimumab therapy: experience from a consecutive cohort of inflammatory bowel disease patients.Antisense approach to inflammatory bowel disease: prospects and challenges.Alleviated mucosal and neuronal damage in a rat model of Crohn's disease.Venous and arterial disease in inflammatory bowel disease.Thromboembolic events and cardiovascular mortality in inflammatory bowel diseases: a meta-analysis of observational studies.Cancer and immunomodulators in inflammatory bowel diseases.Development of the first disability index for inflammatory bowel disease based on the international classification of functioning, disability and healthUnderstanding the health and social care needs of people living with IBD: a meta-synthesis of the evidence.Prevalence and Characteristics of Extra-intestinal Manifestations in a Large Cohort of Greek Patients with Inflammatory Bowel DiseaseClinical features of Crohn disease concomitant with ankylosing spondylitis: A preliminary single-center study.Crohn's disease and ulcerative colitis are associated with elevated standardized mortality ratios: a meta-analysis.Second Korean guidelines for the management of Crohn's disease.Advances in the diagnosis and management of inflammatory bowel disease: challenges and uncertainties.Risk factors for postoperative recurrence of Crohn's disease.Review article: the natural history of postoperative Crohn's disease recurrence.Treatment of extraintestinal manifestations in inflammatory bowel disease.Development of the Paris definition of early Crohn's disease for disease-modification trials: results of an international expert opinion process.Clinical risk factors for complicated disease: how reliable are they?Loss of response to biologics versus increased risk of lymphoma in children with inflammatory bowel disease: the clinician's conundrum.First-line therapy in adult Crohn's disease: who should receive anti-TNF agents?Impact of drug therapy and surgery on quality of life in Crohn's disease: a systematic review.JAK inhibition in inflammatory bowel disease.Th9 cells in inflammatory bowel diseases.Predictive factors for an uncomplicated long-term course of Crohn's disease: a retrospective analysis.Perioperative Blood Transfusion and Postoperative Outcome in Patients with Crohn's Disease Undergoing Primary Ileocolonic Resection in the "Biological Era".A long noncoding RNA signature for ulcerative colitis identifies IFNG-AS1 as an enhancer of inflammation.Suppression of inflammation and tissue damage by a hookworm recombinant protein in experimental colitis.Circulating CD4(+) and CD8(+) T cells are activated in inflammatory bowel disease and are associated with plasma markers of inflammation.Colorectal cancer in inflammatory bowel diseases: a population-based study (1976-2008).The extra burden of infliximab infusions in inflammatory bowel disease.Efficacy and safety of golimumab in Crohn's disease: a French national retrospective study.Psychosocial complications of Crohn’s disease and cause of death.Changing treatment paradigms for the management of inflammatory bowel disease.Ultra-small solid archaeolipid nanoparticles for active targeting to macrophages of the inflamed mucosa.
P2860
Q22305935-8F82734E-A009-413C-AF5E-FD980CC2E0A4Q28506653-F3A9FC2F-F7A3-4CF7-961D-A5CB7418D0D0Q33638449-09C33E85-6E36-4AB2-849D-9F6A08F9A4A5Q33641136-0969EEDF-6EEF-45F1-9733-10A94263AAC9Q33661327-8FA8F8C2-D93E-40E5-923C-865F3C799C24Q33796025-11C786CB-99C5-4EB5-8385-0CEFA43F9E4BQ33829739-A1893E16-4F79-47E1-8807-7F16513397D3Q34473572-A4F201D1-63B9-4B7F-9D7E-C8B60CF204E0Q34589792-8726C33E-2B31-414C-B544-561081F4A8D7Q34714365-7B36206F-BF1B-4286-B14D-CD4CDEB761C9Q35030705-E3AC631A-8A1E-414D-B8CD-5BEF337A51EDQ35534959-76C7D3BC-39C8-4D0D-8192-EFAB2421B896Q35633526-C17FFA35-0D7E-40AE-BFF1-147334B9C1F8Q36410377-BA33A2DA-804B-4BA7-B7B2-99C59BE28548Q37098461-6C9EDE1F-822C-421C-A0CC-1393F4B98C2BQ37116956-5A9CAB54-D135-4D5B-9E3C-5CAADB655D39Q37126766-EFBE9720-3E97-4DAC-AA7C-847DA2AE43B2Q37662498-D7DBAAC8-40D4-48BB-B594-E01A879C8F60Q37703514-9B5164F7-1025-4899-A197-E3A23DFED416Q37708313-83F9C37F-1D80-41E9-8315-6F54D1817497Q37982122-F2B05982-13C5-4864-A1D6-2040BBA20AA7Q38050884-38D1DB7D-F850-4498-B7D9-BD66E6C368BAQ38065036-32903296-4510-4209-83C1-AE29AEF61537Q38072226-9D605F6D-7BFE-415F-98E9-E5703D25D09DQ38079831-39F3C425-90E6-4E3B-AC65-ACA3E4726BDFQ38086355-F2328898-2BB7-46C2-B1D4-6FC6799AAE18Q38430984-0D8E8230-0357-47EB-A3A4-3B86F4031567Q38761142-4E009193-20E9-436A-BAE1-169696585747Q39006003-EEEEDF00-475B-4002-8E9F-4FA1325C85E9Q40266793-1F98C689-C8C0-4E4B-BB37-4FDAB0EAB27DQ40629402-FCF53635-EC05-446F-A41B-FE5A519DBD34Q41546047-52423D7A-6DED-4BA7-BD90-4313387B176BQ45740348-D07489EA-88B3-4720-8565-833162BFEBA3Q45906567-C0D986E4-523A-400A-AEA5-FDCE9C0291D2Q46758744-0358ABA6-D687-4433-9776-9F8EBC73160AQ47785105-4FE492D3-1BE6-420A-9F46-CDB4A2197191Q48191965-6EEFEED6-2F22-419F-8D2E-0D62BACAD184Q48310171-430F0A18-8EAE-47A4-8602-CE9DD8691B69Q48537463-5B90A7FE-076B-494C-B71E-A3570F5F5F18Q51032601-38584C59-B250-497C-A674-CFB8A355FC20
P2860
Long-term complications, extraintestinal manifestations, and mortality in adult Crohn's disease in population-based cohorts.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 August 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Long-term complications, extra ...... e in population-based cohorts.
@en
Long-term complications, extra ...... e in population-based cohorts.
@nl
type
label
Long-term complications, extra ...... e in population-based cohorts.
@en
Long-term complications, extra ...... e in population-based cohorts.
@nl
prefLabel
Long-term complications, extra ...... e in population-based cohorts.
@en
Long-term complications, extra ...... e in population-based cohorts.
@nl
P2860
P50
P356
P1476
Long-term complications, extra ...... e in population-based cohorts.
@en
P2860
P304
P356
10.1002/IBD.21417
P577
2010-08-19T00:00:00Z